July 14, 2020
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, DC 20549-3720
| Attention: | Ada Sarmento |
| Christine Torney |
| Lynn Dicker |
| Mary Beth Breslin |
Re: ALX Oncology Holdings Inc.
Registration Statement on Form S-1 (File No. 333-239490)
Ladies and Gentlemen:
Pursuant to Rule 460 of the General Rules and Regulations under the Securities Act of 1933, as amended, we wish to advise that between July 13, 2020 and the date hereof, approximately 1,505 copies of the Preliminary Prospectus dated July 13, 2020 were distributed to prospective underwriters, institutional investors and prospective dealers in connection with the above-captioned Registration Statement.
We wish to advise you that the participating underwriters have informed us that they have complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
We hereby join in the request of the registrant that the effectiveness of the above-captioned Registration Statement, as amended, be accelerated to 4:00 p.m. Eastern Time, on July 16, 2020 or as soon thereafter as practicable.
[Signature page follows]
Very truly yours,
JEFFERIES LLC
CREDIT SUISSE SECURITIES (USA) LLC
PIPER SANDLER & CO.
CANTOR FITZGERALD & CO.
As representatives of the Underwriters
| By: Jefferies LLC | ||
| By: |
/s/ Michael Brinkman | |
| Name: Michael Brinkman Title: Managing Director | ||
| By: Credit Suisse Securities (USA) LLC | ||
| By: | /s/ Andrew E. Singer | |
| Name: Andrew E. Singer | ||
| Title: Managing Director | ||
| By: Piper Sandler & Co. | ||
| By: | /s/ Chad Huber | |
| Name: Chad Huber | ||
| Title: Managing Director | ||
| By: Cantor Fitzgerald & Co. | ||
| By: | /s/ Sage Kelly | |
| Name: Sage Kelly | ||
| Title: Senior Managing Director | ||
[Signature Page to Underwriters Acceleration Letter]